Results 81 to 90 of about 23,148 (170)

Pioglitazone improves the cardio-ankle vascular index in patients with type 2 diabetes mellitus treated with metformin

Diabetes, Metabolic Syndrome and Obesity, 2014
Masahiro Ohira,1 Takashi Yamaguchi,1 Atsuhito Saiki,1 Noriko Ban,1 Hidetoshi Kawana,1 Ayako Nagumo,1 Takeyoshi Murano,2 Kohji Shirai,3 Ichiro Tatsuno1 1Center for Diabetes, Endocrinology and Metabolism, 2Department of Clinical Laboratory Medicine ...
Ohira M, Yamaguchi T, Saiki A, Ban N, Kawana H, Nagumo A, Murano T, Shirai K, Tatsuno I   +8 more
doaj  

Risk management in the treatment of type 2 diabetes with pioglitazone

Diabetes, Metabolic Syndrome and Obesity, 2009
Giuseppe Derosa, Sibilla AT SalvadeoDepartment of Internal Medicine and Therapeutics, University of Pavia, Pavia, ItalyIntroduction: Type 2 diabetes mellitus is one of the most important cardiovascular risk factors.
Giuseppe Derosa, Sibilla AT Salvadeo
doaj  

Cost‐Utility Analysis of Low‐Dose Pioglitazone in a Population With Prediabetes and a History of Stroke or Transient Ischemic Attack

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background Pioglitazone significantly reduces the risk of stroke in people with diabetes, and in those with prediabetes, it markedly reduces the risk of stroke/myocardial infarction and new‐onset diabetes.
Fei Yuan, J. David Spence, Jean‐Eric Tarride   +2 more
doaj   +1 more source

Combination therapy with DPP-4 inhibitors and pioglitazone in type 2 diabetes: theoretical consideration and therapeutic potential

Vascular Health and Risk Management, 2008
Nasser MikhailEndocrinology Division, Olive View-UCLA Medical Center, David-Geffen School of Medicine, CA, USAAbstract: Sitagliptin and vildagliptin represent a new class of anti-diabetic agents that enhance the action of incretin hormones through ...
Nasser Mikhail
doaj  

Targeting the PPAR-γ-ABC transporter axis ameliorates secondary pulmonary alveolar proteinosis induced by indium oxide nanoparticles. [PDF]

Part Fibre Toxicol
Jeon S, Kim G, Cho WS.
europepmc   +1 more source

Pioglitazone mitigates early brain injury by suppressing neuroinflammation and oxidative stress after subarachnoid hemorrhage: a rodent model study. [PDF]

Ann Med
Cetinkaya K, Özates MÖ, Kullukçu H, Ünsal Y, Kazancı A, Gürcan O, Önder E, Deveci Bulut TS, Gürcay AG.   +8 more
europepmc   +1 more source

Effect of Locally-Administered Pioglitazone on the Survival of Dermal Skin Flaps in an Experimental Study on Rats. [PDF]

Cureus
Basagiannis ED, Damaskos C, Garmpis N, Kykalos S, Papalampros A, Nikiteas N.   +5 more
europepmc   +1 more source

Pioglitazone

Reactions Weekly, 2015
Sanjay, Kalra, Yashdeep, Gupta
openaire   +3 more sources

Tracking of Neuroinflammation Dynamics During Combined Anti-β-Amyloid Therapy (AAT) and Immunomodulation in a Preclinical Alzheimer's Disease Model. [PDF]

Int J Mol Sci
Wind-Mark K, Kunze LH, Willem M, Palumbo G, Giudici C, Nuscher B, Boening G, Gildehaus FJ, Lindner S, Werner RA, Franzmeier N, Gnörich JS, Brendel M, Zatcepin A.   +13 more
europepmc   +1 more source

Effects of PPARα, PPARγ, and dual PPARα/γ agonists on liver tissue and biochemical markers in NAFLD-induced Wistar rats. [PDF]

Res Pharm Sci
Khoshbakht E, Dinarvand N, Yaghooti H, Taheri B, Mohammadtaghvaei N.   +4 more
europepmc   +1 more source